Netskope, Inc., a cybersecurity company, provides security, networking, and analytics solutions to largest enterprises to mid-sized companies worldwide.
FAIL · Does not pass the screen
22.00 USD
Price as of 2 Nov 2026Daily close, not a live quote
Screened 2026-11-02 · the tape above runs as of 14:04 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Positioning no disclosures inside 60 days, left as found
Options put/call open interest 0.16, read 2026-11-02
Ethical does not pass the values gate
Price22.00 USD
Fair value12.15
Ethical score70.0/100
Our investment reviews on this name
2026-10-11Read Accumulation17.85+23.2% to today ✓Markup gives way to Accumulation after a 32% rise in 6 weeks
2026-08-28Read Markup13.50+63.0% to today ✓Accumulation gives way to Markup first Markup read since August
2026-08-26Read Accumulation13.50+63.0% to today ✓Markup gives way to Accumulation first Accumulation read since July
2026-08-07Read Markup13.59+61.9% to today ✓Accumulation gives way to Markup after a 50% rise in 5 weeks
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
Netskope, Inc. holds its Accumulation at $22.00. Consolidating, no directional conviction, held for 70 days.
As held on the ledger · 2026-11-02
Phase
Accumulation
Quantitative state
Consolidating, no directional conviction, held for 70 days
Price at the screen
$22.00
Valuation
N/A trailing · 713.98 forward price to earnings
Values screen
FAIL· score 70.0
The Workings
Five Screens, Shown in Full
Does not pass. Debt ratio
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
42.61%
Below 33%
Interest-bearing debt is 42.6% of its assets, above the one-third ceiling the screen allows.
Fail
Interest-bearing cash
40.94%
Below 33%
Interest-bearing cash and securities are 40.9% of assets, above the one-third limit.
Fail
Receivables
33.34%
Below 49%
Money owed to the company is 33.3% of assets, under the 49% limit.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical Read
Why It Falls Short, in Plain English
Netskope,'s business is in a permissible area, but its interest-bearing debt is about 43% of the company, well over the ~33% line, so it does not pass on the financial screens.
Read as at 2026-11-02. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when NTSK's ethical verdict changes
Today NTSK does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
Fair value range in USD, drawn from the 2026-11-02 screen. The gold marker is the market price at the same screen. The price runs 50.0% above the base estimate.
Where our models see it going: fair-value estimate $12.15, range not available, dated to the 2026-11-02 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Cloud Security Name Priced Well Beyond Reality
Picture a mid-sized firm moving its entire workforce online. Every click and file transfer now needs protection that older tools cannot provide. Netskope sells exactly that service through its cloud platform and revenue is rising 28 percent a year. Yet the shares sit at 955 times forward earnings while the company loses 95 cents on every dollar of sales. Our fair value sits 42 percent below the current price, so the opportunity rating is none.
The market appears to be betting that rapid adoption will soon turn those losses into fat profits. Analyst targets cluster around 16 dollars, well above where we see fair value. Growth alone does not justify such a multiple when margins remain deeply negative and the moat is still unproven.
High expectations leave little room for the usual delays that hit software roll-outs. Currency moves or a slower shift to cloud tools could widen losses further. The ethical screen is clear, yet the numbers still point to material downside from here. Analysis, not advice.
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The things to watch: it carries a real debt load, which raises the stakes if revenue slips.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
NTSK trades on Nasdaq. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-11-01Accumulation$24.30+22.6%Entry 17
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 22.6% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B. Technically it is momentum reading overbought. Our forward projection puts the odds of a 10% gain over the next month near 17%. The street (18 analysts) rates it strong buy, with a mean price target of $18. Insiders have been net sellers over the past quarter.
2026-10-25Accumulation$19.82-1.1%Entry 16
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 1.1% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B. Technically it is momentum reading neutral. Our forward projection puts the odds of a 10% gain over the next month near 17%. The street (18 analysts) rates it strong buy, with a mean price target of $18. Insiders have been net sellers over the past quarter.
2026-10-18Accumulation$20.04+12.3%Entry 15
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 12.3% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B. Technically it is momentum reading neutral. Our forward projection puts the odds of a 10% gain over the next month near 17%. The street (18 analysts) rates it strong buy, with a mean price target of $18. Insiders have been net sellers over the past quarter.
The framework has shifted from markup to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B. Technically it is momentum reading neutral. Our forward projection puts the odds of a 10% gain over the next month near 17%. The street (18 analysts) rates it strong buy, with a mean price target of $18. Insiders have been net sellers over the past quarter.
2026-10-02Markup$17.85+32.2%Entry 13
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 32.2% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C. Technically it is momentum reading neutral. Our forward projection puts the odds of a 10% gain over the next month near 17%. The street (18 analysts) rates it strong buy, with a mean price target of $18. Insiders have been net sellers over the past quarter.
2026-09-02Markup$13.50+0.0%Entry 12
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C. Technically it is momentum reading neutral. Our forward projection puts the odds of a 10% gain over the next month near 17%. The street (18 analysts) rates it strong buy, with a mean price target of $18. It reported earnings in this window, a natural checkpoint for the thesis.
2026-09-01Markup$13.50+0.0%Entry 11
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C. Technically it is momentum reading neutral. Our forward projection puts the odds of a 10% gain over the next month near 17%. The street (18 analysts) rates it strong buy, with a mean price target of $18. It reported earnings in this window, a natural checkpoint for the thesis.
2026-08-31Markup$13.50+0.0%Entry 10
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C. Technically it is momentum reading neutral. Our forward projection puts the odds of a 10% gain over the next month near 17%. The street (18 analysts) rates it strong buy, with a mean price target of $18. It reported earnings in this window, a natural checkpoint for the thesis.
2026-08-30Markup$13.50+0.0%Entry 9
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C. Technically it is momentum reading neutral. Our forward projection puts the odds of a 10% gain over the next month near 17%. The street (18 analysts) rates it strong buy, with a mean price target of $18. It reported earnings in this window, a natural checkpoint for the thesis.
2026-08-29Markup$13.50+0.0%Entry 8
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C. Technically it is momentum reading neutral. Our forward projection puts the odds of a 10% gain over the next month near 17%. The street (18 analysts) rates it strong buy, with a mean price target of $18. It reported earnings in this window, a natural checkpoint for the thesis.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.